1832 Asset Management’s Oncolytics Biotech ONCY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-5
| Closed | -$5 | – | 826 |
|
|
2024
Q2 | $5 | Hold |
5
| – | – | ﹤0.01% | 877 |
|
|
2024
Q1 | $5 | Hold |
5
| – | – | ﹤0.01% | 873 |
|
|
2023
Q4 | $7 | Hold |
5
| – | – | ﹤0.01% | 821 |
|
|
2023
Q3 | $10 | Hold |
5
| – | – | ﹤0.01% | 845 |
|
|
2023
Q2 | $13 | Hold |
5
| – | – | ﹤0.01% | 843 |
|
|
2023
Q1 | $6 | Hold |
5
| – | – | ﹤0.01% | 881 |
|
|
2022
Q4 | $8 | Hold |
5
| – | – | ﹤0.01% | 877 |
|
|
2022
Q3 | $0 | Hold |
5
| – | – | ﹤0.01% | 886 |
|
|
2022
Q2 | $0 | Hold |
5
| – | – | ﹤0.01% | 899 |
|
|
2022
Q1 | $0 | Hold |
5
| – | – | ﹤0.01% | 939 |
|
|
2021
Q4 | $0 | Hold |
5
| – | – | ﹤0.01% | 827 |
|
|
2021
Q3 | $0 | Hold |
5
| – | – | ﹤0.01% | 875 |
|
|
2021
Q2 | $0 | Hold |
5
| – | – | ﹤0.01% | 763 |
|
|
2021
Q1 | $0 | Hold |
5
| – | – | ﹤0.01% | 754 |
|
|
2020
Q4 | $0 | Sell |
5
-421
| -99% | – | ﹤0.01% | 735 |
|
|
2020
Q3 | $1K | Hold |
426
| – | – | ﹤0.01% | 677 |
|
|
2020
Q2 | $1K | Hold |
426
| – | – | ﹤0.01% | 639 |
|
|
2020
Q1 | $1K | Buy |
426
+421
| +8,420% | +$988 | ﹤0.01% | 658 |
|
|
2019
Q4 | $0 | Hold |
5
| – | – | ﹤0.01% | 725 |
|
|
2019
Q3 | $0 | Hold |
5
| – | – | ﹤0.01% | 735 |
|
|
2019
Q2 | $0 | Hold |
5
| – | – | ﹤0.01% | 740 |
|
|
2019
Q1 | $0 | Hold |
5
| – | – | ﹤0.01% | 687 |
|
|
2018
Q4 | $0 | Hold |
5
| – | – | ﹤0.01% | 701 |
|
|
2018
Q3 | $0 | Hold |
5
| – | – | ﹤0.01% | 701 |
|
|
2018
Q2 | $0 | Buy |
+5
| New | – | ﹤0.01% | 713 |
|